MassAffinity empowers pharmaceutical and biotechnology partners to accelerate drug discovery for undruggable and complex targets through our native mass spectrometry workflows.

Our platform delivers fast, direct insight into molecular interactions, helping partners de-risk early-stage discovery and unlock new treatment opportunities for unmet medical needs.